Integer and Mainstay Extend Relationship through New Supply Agreement

FRISCO, Texas, Jan. 19, 2017 -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource (MDO) manufacturer, today announced that its subsidiary, Centro de Construccion de Cardioestimuladores del Uruguay S.A. (CCC), has signed a new supply agreement with Mainstay Medical Limited (MML), a subsidiary of Mainstay Medical International plc (Mainstay).

The supply agreement becomes effective in January 2017 and replaces the engineering agreement that has been in place since 2010. Under the supply agreement, CCC will continue as the exclusive manufacturer of the implantable pulse generator and certain accompanying technology, including software, for MML’s ReActiv8^® system. ReActiv8 is an implantable neurostimulation system used to treat disabling Chronic Low Back Pain (CLBP).

“Our agreement with Mainstay further demonstrates Integer’s growing position as a key service provider in the development and manufacturing of integrated systems within the active implantable market,” said Tony Gonzalez, president of Integer’s Cardiac Rhythm Management & Neuromodulation product category. “We are excited to extend our partnership with Mainstay and we look forward to our continued role in helping Mainstay bring ReActiv8 to market. Through their relationship with us, Mainstay is able to leverage our core technology and manufacturing footprint to more efficiently and cost-effectively bring the ReActiv8 system to patients suffering from CLBP.”

Peter Crosby, Mainstay’s CEO, said, “We are pleased to complete the new supply agreement with CCC as we advance our commercialization activities relating to ReActiv8.”

About Integer™ 
Integer Holdings Corporation (NYSE:ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, orthopedics, vascular, advanced surgical and portable medical markets. The company provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. The company's brands include Greatbatch^TM Medical, Lake Region Medical^TM and Electrochem^TM. Additional information is available at www.integer.net.

Integer Contacts
Investor Relations
Amy Wakeham
[email protected]
214.618.4978

Media Relations
Jeannine Lee
[email protected]
972.668.4593